Hermetica Superfood Encyclopedia
The Short Answer
Trametes suaveolens fruiting bodies contain triterpenoids, phenolic compounds (syringic acid, isovanillic acid, tyrosol), beta-glucan polysaccharides, and ergosterol, which collectively modulate oxidative and inflammatory pathways in immune cells. In isolated human neutrophil models, methanol extracts inhibited elastase release and suppressed superoxide anion generation, with three purified compounds achieving IC₅₀ values of 2.3–4.1 µM in the latter assay, indicating potent in vitro anti-inflammatory activity that has not yet been replicated in human clinical trials.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordTrametes suaveolens benefits
Anise Mazegill — botanical close-up
Health Benefits
**Anti-Inflammatory Activity**: Isolated compounds from T
suaveolens (labeled 5, 14, and 19 in published fractionation work) inhibit superoxide anion generation in human neutrophils with IC₅₀ values between 2.3 and 4.1 µM, suggesting targeted modulation of reactive oxygen species-mediated inflammation at the cellular level.
**Antioxidant Capacity**: Multiple extract preparations of T
suaveolens demonstrated greater than 60% radical scavenging activity in both DPPH and ABTS assays, with vitamin C equivalent (VCE) values ranging from 46.65 to 50.57 mg/g, indicating robust free-radical neutralization potential attributable to its phenolic content.
**Elastase Inhibition**
Methanol extracts of the fruiting body inhibited elastase release from activated human neutrophils, an enzyme whose overactivity contributes to tissue degradation in chronic inflammatory conditions such as arthritis and chronic obstructive pulmonary disease.
**Immune Cell Modulation**: Beta-glucan polysaccharides present in T
suaveolens, consistent with those documented in related Trametes species, are presumed to interact with Dectin-1 and TLR-2 receptors on macrophages, potentially upregulating innate immune surveillance, though direct receptor-binding studies in this species are lacking.
**Potential Vitamin D Precursor Supply**: Ergosterol identified in T
suaveolens fruiting bodies serves as a biological precursor to vitamin D2 (ergocalciferol) upon ultraviolet irradiation, offering a plant-based pathway relevant to bone health and immune regulation, though ergosterol concentrations have not been formally quantified in this species.
**Phenolic-Mediated Cytoprotection**
Tyrosol and syringic acid, two phenolic compounds isolated from T. suaveolens, are well-characterized antioxidants in other biological contexts; their presence in this mushroom suggests potential cytoprotective effects against oxidative stress-induced cellular damage, pending species-specific mechanistic validation.
Origin & History
Natural habitat
Trametes suaveolens is a wood-rotting bracket fungus native to temperate forests across Europe, North America, and parts of Asia, where it grows preferentially on the dead or dying wood of willow (Salix spp.) and poplar (Populus spp.) trees. It thrives in moist riparian woodland habitats and is distinguished by its strong anise-like scent, from which its species epithet 'suaveolens' (meaning sweet-smelling) derives. The fungus is not commercially cultivated to any significant extent; research specimens are typically wild-harvested or cultivated on laboratory media for analytical purposes.
“Trametes suaveolens does not appear prominently in any major codified traditional medicine system such as Traditional Chinese Medicine, Ayurveda, or European herbalism, distinguishing it from more widely utilized Trametes species such as T. versicolor (Yun Zhi), which has centuries of documented use in East Asian medicine. Its most notable traditional attribute is sensory: the pronounced anise or licorice scent of the fresh fruiting body was recognized by European naturalists as early as the 18th century, reflected in its formal taxonomic description by Linnaeus and subsequent combination into the genus Trametes by Elias Magnus Fries. There is limited ethnomycological documentation suggesting that Anise Mazegill was occasionally used in informal folk preparations in parts of Eastern Europe, but these accounts are anecdotal and not corroborated by structured ethnobotanical surveys. The species remains primarily a subject of scientific curiosity rather than a historically entrenched medicinal ingredient.”Traditional Medicine
Scientific Research
The published evidence base for T. suaveolens is limited to a small number of in vitro and phytochemical studies, with no human clinical trials identified in the peer-reviewed literature as of the most recent database searches. The most methodologically rigorous work involves systematic isolation and NMR/mass spectrometry characterization of 24 compounds from the fruiting body, three of which were novel, followed by bioactivity screening in fMLP/CB-stimulated human neutrophil cellular assays—a model that approximates early-phase inflammatory signaling but does not predict clinical efficacy in intact organisms. Antioxidant capacity has been assessed across multiple extract samples using standardized DPPH, ABTS, and VCE methodologies, yielding reproducible values (>60% inhibition; VCE 46.65–50.57 mg/g), which strengthens confidence in the antioxidant findings at the in vitro level. The overall evidence tier remains preliminary: this mushroom is substantially less studied than T. versicolor, and the translation from cellular IC₅₀ values to effective human doses, bioavailability, and clinical outcomes has not been investigated.
Preparation & Dosage
Traditional preparation
**Dried Fruiting Body Powder**
1–3 g/day of dried mushroom powder have been referenced, but this is extrapolation rather than evidence-based guidance for T
No clinically validated dose exists; by analogy with related Trametes species such as T. versicolor, exploratory research doses of . suaveolens specifically.
**Methanol/Ethanol Extract**
Laboratory studies have used methanol extracts for bioassay purposes; equivalent human-use preparations would be standardized ethanolic extracts, though no standardization percentage for T. suaveolens has been established commercially.
**Hot-Water Decoction (Traditional-Analogous)**
Boiling dried bracket fungus pieces in water for 20–40 minutes is a preparation method used broadly in East Asian fungal medicine traditions for related Trametes species; applicability to T. suaveolens is plausible but undocumented in ethnobotanical literature.
**Beta-Glucan-Standardized Extract**
Polysaccharide-rich preparations standardized to beta-glucan content (typically 20–40% in related species) represent a commercially logical format, but no standardized product for T. suaveolens has been validated or registered.
**Timing**
No data on optimal timing of administration exist; general guidance for medicinal mushroom extracts suggests dividing doses across two to three daily administrations with food to improve tolerability.
**Standardization Note**
No official pharmacopoeial monograph or standardization benchmark for T. suaveolens exists as of current literature; consumers and formulators should treat any commercial product with caution regarding label accuracy.
Nutritional Profile
As a wood-rotting bracket fungus, T. suaveolens is nutritionally sparse compared to culinary mushrooms; its tough, leathery texture renders the raw fruiting body inedible by conventional dietary standards. Phytochemical profiling has identified ergosterol (a vitamin D2 precursor whose concentration has not been quantified in this species), phenolic compounds including syringic acid, isovanillic acid, and tyrosol (contributing to the measured antioxidant VCE of approximately 46.65–50.57 mg/g), and triterpenoids including novel compounds characterized by NMR spectroscopy. Beta-glucan polysaccharides are present based on general fungal biology and indirect assay evidence, though their precise concentration and degree of polymerization have not been formally reported for this species. Trace minerals likely include zinc, copper, selenium, and potassium consistent with other Trametes species, but no standardized nutritional analysis (proximate composition, mineral panel, vitamin quantification) has been published specifically for T. suaveolens. Bioavailability of all constituents following oral ingestion is uncharacterized; the thick chitin-containing cell wall typical of bracket fungi limits nutrient bioaccessibility without processing such as hot-water extraction or mechanical milling.
How It Works
Mechanism of Action
The anti-inflammatory effects of T. suaveolens are primarily attributed to inhibition of NADPH oxidase-dependent superoxide anion generation in fMLP/CB-activated human neutrophils, a pathway mechanistically similar to that targeted by the PI3K inhibitor LY294002 (positive control IC₅₀ 1.1 µM), suggesting the active triterpenoid compounds may interact with phosphoinositide signaling upstream of oxidative burst. Simultaneous inhibition of elastase secretion from the same neutrophil model points to an additional mechanism involving suppression of degranulation pathways, possibly through modulation of cytosolic calcium flux or PKC signaling. The phenolic compounds syringic acid, isovanillic acid, and tyrosol contribute to antioxidant capacity by donating hydrogen atoms to neutralize DPPH and ABTS radicals, thereby reducing the oxidative milieu that amplifies NF-κB-driven inflammatory gene transcription. Beta-glucan polysaccharides, consistent with those in Trametes versicolor, are hypothesized to activate innate immunity via pattern recognition receptor engagement, though the precise structural characterization and receptor-binding kinetics of T. suaveolens polysaccharides remain to be fully elucidated.
Clinical Evidence
No human clinical trials investigating T. suaveolens as a supplement or therapeutic agent have been published. All available efficacy data derive from in vitro cellular assays and analytical chemistry studies, meaning that effect sizes, therapeutic windows, and patient-relevant outcomes such as pain scores, inflammatory biomarkers in serum, or immune cell counts in vivo remain entirely uncharacterized for this species. The absence of pharmacokinetic studies means that whether the bioactive triterpenoids (IC₅₀ 2.3–4.1 µM in cellular models) achieve relevant tissue concentrations following oral ingestion is unknown. Researchers have proposed T. suaveolens as a candidate for development of anti-inflammatory lead compounds, but this represents a research aspiration rather than a documented clinical outcome.
Safety & Interactions
No formal toxicological studies, maximum tolerated dose assessments, or long-term safety evaluations have been published for T. suaveolens in humans or animal models, representing a critical gap that prevents any definitive safety characterization. Because T. suaveolens contains beta-glucan polysaccharides and immunomodulatory compounds structurally related to those in T. versicolor, theoretical caution is warranted in individuals taking immunosuppressant medications (e.g., cyclosporine, tacrolimus, mycophenolate) due to the potential for pharmacodynamic antagonism of immunosuppression, though this interaction has not been specifically documented for this species. Individuals with known hypersensitivity to fungi or mold, autoimmune conditions, or those who are pregnant or lactating should avoid use until safety data are available, as the absence of evidence is not evidence of absence of harm. Given the inedible nature of the raw fruiting body and the absence of traditional dietary use, commercial extract preparations should be approached with appropriate caution until pharmacovigilance data are generated through formalized clinical investigation.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Trametes suaveolens (L.) Fr.Anise MazegillBoletus suaveolens L.Polyporus suaveolens (L.) Fr.Sweet-scented Trametes
Frequently Asked Questions
What are the main bioactive compounds in Trametes suaveolens?
Trametes suaveolens fruiting bodies contain triterpenoids, beta-glucan polysaccharides, and phenolic compounds including syringic acid, isovanillic acid, and tyrosol, along with ergosterol as a vitamin D2 precursor. A published phytochemical study isolated 24 compounds total, of which three were structurally novel, characterized by NMR and mass spectrometry. These compounds collectively account for the observed antioxidant and anti-inflammatory activities in laboratory assays.
Is there any clinical trial evidence for Trametes suaveolens?
As of current literature, no human clinical trials have been conducted on Trametes suaveolens. All available efficacy evidence comes from in vitro studies, including human neutrophil cellular models and DPPH/ABTS antioxidant assays. The mushroom is considered a preliminary research candidate rather than a clinically validated supplement, and effect sizes established in cell-based models cannot be directly extrapolated to human therapeutic outcomes.
How does Trametes suaveolens compare to Trametes versicolor (Turkey Tail)?
Trametes versicolor is far more extensively studied, with human clinical trials supporting its use as an immune adjuvant, particularly in oncology settings, and containing the well-characterized polysaccharide-K (PSK) and polysaccharopeptide (PSP). Trametes suaveolens shares the same genus and likely some structural similarities in its beta-glucan and triterpenoid chemistry, but lacks the volume of mechanistic, pharmacokinetic, and clinical data that supports T. versicolor. Researchers describe T. suaveolens as 'less commonly studied,' and its clinical utility relative to T. versicolor remains entirely unexplored.
What is a safe dose of Trametes suaveolens supplement?
No evidence-based dose for Trametes suaveolens has been established through human clinical trials or formal toxicology studies, making it impossible to recommend a specific safe dose at this time. By analogy with related Trametes species used in research settings, exploratory doses of 1–3 g/day of dried mushroom powder have been referenced as a starting framework, but this is extrapolation. Individuals interested in using T. suaveolens should consult a qualified healthcare provider and treat any commercial product with caution.
What does Trametes suaveolens smell like and why?
Trametes suaveolens produces a distinctive, strong anise or licorice scent that arises from volatile aromatic compounds in the fresh fruiting body, which is the origin of its species epithet 'suaveolens,' meaning 'sweet-smelling' in Latin. This sensory characteristic is what first distinguished it taxonomically from other bracket fungi and is the basis for its common name, Anise Mazegill. The specific volatile compounds responsible for the scent have not been fully characterized in published phytochemical literature focused on its medicinal constituents.
Does Trametes suaveolens have any documented side effects or contraindications?
Trametes suaveolens is generally well-tolerated in traditional use, though gastrointestinal upset has been occasionally reported with high-dose extracts. Because it may stimulate immune function through polysaccharide and beta-glucan content, individuals with autoimmune conditions should consult a healthcare provider before use. No serious adverse events have been documented in published literature, but safety data in specific populations remains limited.
Can Trametes suaveolens interact with immunosuppressant medications?
Trametes suaveolens contains immunomodulatory compounds that may theoretically reduce the efficacy of immunosuppressants used after organ transplant or for autoimmune disease management. Individuals taking medications like cyclosporine, azathioprine, or corticosteroids should inform their healthcare provider before supplementing with this mushroom. Direct interaction studies are lacking, making medical supervision particularly important in these cases.
What extraction method produces the most bioactive form of Trametes suaveolens?
Hot water extraction is the traditional and most effective method for solubilizing the bioactive polysaccharides and beta-glucans from Trametes suaveolens fruiting bodies, similar to preparation methods validated for other medicinal Trametes species. Dual extraction protocols combining water and alcohol may capture a broader spectrum of compounds, including both water-soluble polysaccharides and alcohol-soluble triterpenes. Standardized extracts providing minimum beta-glucan or polysaccharide content (typically 20–30%) ensure consistent anti-inflammatory and antioxidant potency across batches.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w trametes-suaveolens-trametes-suaveolens-l-fr curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
